Dr. PARKES WEBER, in reply, said he had not yet seen a good result in a case of this kind follow peri-arterial sympathectomy. Anyhow, he thought that a thorough trial of one of the newer drugs, such as angioxyl, should be made before resorting to operation.
Dr. A. M. H. GRAY said that one of his patients with a similar condition had had peri-arterial sympathectomy performed. Following it there was a slight transitory improvement, but as the condition relapsed, no permanent effect had occurred.
Lichen Planus Atrophicus.-H. W. BARBER, M.B., F.R.C.P. Patient, Mrs. I. S., aged 66 . This is a very extensive and characteristic case of atrophic lichen planus. The eruption began on the abdomen in February 1930, and its onset was accompanied by tenderness in the affected skin and some itching.
At the present time there are symmetrically grouped pearly-white papules on the anterior surface of the wrists. On the flexor surfaces of the arms, on the neck, abdomen and thighs, and in the groins are oval or irregular patches, some with lilaccoloured borders, but white and atrophic in the centre. Some of the papules show the characteristic horny plugs in the orifices of the sweat ducts or follicles. There are no mucous membrane lesions.
The case shown by Sir Ernest Graham-Little (see p. 75) seems to be of the same nature.
Di8cU88ion.-The PRESIDENT said he thought some of the lesions in the clavicular region bore rather close resemblance to " white spot disease " (morphaea guttata), and he was not surprised that some confusion existed between the two conditions. Dr. BARBER (in reply) said that in some cases of " white spot disease " the condition was atrophic lichen planus, in others guttate morphaea. During the past few years Dr. Forman and I have been treating several cases of staphylococcal sycosis and a few of simple furunculosis by means of intradermal injections of a mixed stock staphylococcal vaccine. The results have been so satisfactory that we thought the Section might be interested to see some of our cases of sycosis thus treated, since the experience of other Members is probably in accordance with our own as regards the futility of the usual methods of treatment of this complaint, including subcutaneous vaccination. Neither the theory nor the practice of intradermal vaccination is new, and we therefore make no claim to originality.
Sycosis Treated by Intradermal
We have found a high degree of hypersensitiveness to the staphylococcus in the skin of these patients, as evidenced by the marked local reaction that occurs when even small doses-e.g., ten million of staphylococcal vaccine-are injected intradermally into the skin of the forearm. Apart from this local reaction, a focal reaction is easily produced by overdosage. Our practice has been to begin with a small dose, which is not increased so long as it provokes a local reaction. When this dose is tolerated without a reaction, a larger one is given and continued until this too is tolerated, when a further increase is made. In this way the antibody production by the skin is gradually stimulated, until eventually large doses, e.g., 750 to 1,000 million, may be given without local or focal reactions, and by this time the sycosis and, if present, the blepharitis are greatly improved or cured.
The treatment may be tedious, and demands careful supervision, because too large an initial dose or too rapid an increase will aggravate the sycosis. It is advisable to begin with ten or even five million organisms, and the dose should never be increased if the local reaction is marked. At first we injected the vaccine intradermally at several sites actually into the sycotic areas, but we are satisfied that equally good, if not better, results are obtained if the injections are made into the skin of the forearm or thigh, and it is then much easier to judge the degree of local reaction and thereby to regulate the dosage. Improvement is admittedly slow, but with careful dosage it is progressive, and no other method of treatment in our hands has given comparable results. We believe that it is applicable to infections other than staphylococcal, e.g., with streptococci, and the higher fungi. ILLUSTRATIVE CASES. (I) W. D., aged 28. This patient has had sycosis for about six and a half years. It began as a small patch on the left side of the chin, and later involved the whole beard region and moustache. He was treated at St. John's Hospital about five years ago, where he had one dose of X-rays with only short temporary improvement; then at Blackfriars Hospital, where he had another X-ray treatment; then at St. Paul's with ultra-violet light and subcutaneous vaccine for eighteen months with considerable benefit, but subsequent relapse.
He came to Guy's Hospital on July 1, 1930, with severe sycosis of the whole beard region and moustache. He has been treated with intradermal injections of a stock staphylococcal vaccine, beginning with 25 million. At first very marked local reactions occurred at the sites of injection, but he now tolerates 1,500 million with very little reaction. He has improved steadily.
Under treatment with intradermal vaccine about ten and a half months.
(II) H. W., aged 34. This patient developed sycosis and blepharitis about ten years ago. He was treated by a bacteriologist with vaccine, and the sycosis improved very considerably, the eyelids less so. The sycosis, however, never really cleared up.
He came to Guy's Hospital in September, 1930, with an attack of impetigo contagiosa and an exacerbation of the sycosis and blepharitis of six months' duration. He was treated in the bacteriological department with subcutaneous injections of a mixed streptococcal and staphylococcal vaccine from September, 1930 , to February, 1931 . His impetigo cleared up, but the sycosis and blepharitis persisted.
In February, 1931, we began treatment with intradermal injections of the mixed staphylococcal vaccine, and from that time he has made steady improvement. Both the sycosis and the blepharitis have practically cleared up. He is now having 500 million with very little local reaction.
Under treatment with intradermal vaccine about three months. (III) T. B., aged 41. This patient has had chronic blepharitis since childhood. Fifteen years ago he developed ? sycosis of the hairy parts of the thighs. The face became affected about ten years ago, and the scalp in February, 1931. He came to Guy's Hospital March 5, 1931. He then had very severe blepharitis and sycosis of the moustache and chin; also an acute infective eezematoid dermatitis of the scalp with some acne necrotica lesions, the scars of which are visible.
He was given 25 million of the mixed staphylococcal vaccine as a first dose, and this produced a very strong local reaction. He is now having 150 million.
His improvement has been extraordinarily rapid as regards the scalp and the sycosis, and his eyelids are gradually improving.
Under treatment by intradermal vaccine about ten weeks. (V) Sidney Smith. First seen in 1928. History of a year's involvement of the face on both cheeks. Treated once by X-rays, but no cure resulted.
From January, 1930 , to February, 1931 Besredka has for some time taught that local or tissue immunity is important in some infections, and that this immunity does not depend on the presence of antibodies in the serum-the agglutinins, the precipitins, aggressins, opsonins, etc., which are generally accepted as being concerned in the production of immunity. For example, in an anthrax immune animal none of these bodies is to be found. Again, a satisfactory antistaphylococcal serum cannot be obtained, suggesting that antibodies are not to be found in the serum after the vaccination of animals.
The staphylococcus is a normal inhabitant of the skin and a staphylococcal infection of the skin is nearly always to be found before the involvement of internal structures, e.g., bones, kidneys, etc.; these facts suggest that it is the skin cells which are sensitive, and that it is in and around these cells that immunity is, or fails to be, developed.
Referring again to anthrax, it is known that if the bacillus is introduced beneath the skin in such a manner as to leave the skin intact, the animal does not become infected [1] . If, however, the skin is inoculated with anthrax, infection immediately takes place, with a fatal septicemic termination.
Further, it is possible to immunize the guinea-pig rapidly by intracutaneous injections of anthrax bacilli. This method of immunizing animals has been widely adopted, with favourable results, by the French Veterinary Service in the anthraxinfected districts of Northern Africa [2] .
As Cannon points out [3] , if antibodies are absent from the circulation, it does not preclude the possibility of their being within the cells or around them in localized areas of immune tissue.
Anatomically, around the site of a staphylococcal intradermal injection there is an increase of macrophages and polymorphonuclear leucocytes, and subsequent inoculation of living organisms shows that the organisms are limited in their spread, clumped and phagocytosed, while in untreated skin the living organisms will multiply rapidly and spread diffusely.
The objection may be raised that there is no evidence that this immunity is other than purely local, due to the tissue changes occurring as a response to the injection. Using the pneumococcus, Julianelle has shown that intradermal inoculation in rabbits produces an immunity to subsequent intravenous inoculation with living organisms; further, that if the immune rabbit's serum is injected into the mouse, the immunity is not transferred.
Again, Julianelle [4] found that if pneumococci are injected into the skin of a rabbit weekly, the cutaneous reactions increase up to the fifth week and then become gradually much less; when the skin reaction has become minimal the general immunity of the animal rises. Besredka claims that cuti-immunization against staphylococci gives an immunity which extends over the entire organism.
Afremow and Pilot [51 in a series of 1,700 normals found that 47% gave a positive reaction to intradermal staphylococcal vaccine. In a second series of thirty-six cases, showing acute or chronic staphylococcal infections, 90% gave a positive reaction.
Jausion states [61 that it is particularly in cases of staphylococcal lesions, e.g., boils, that there is a well-marked response to intracutaneous staphylococcal injections. In a series of ninety-one cases from Dr. Barber's clinic, which included cases of erythema multiforme, lupus erythematosus and psoriasis, 22% gave a positive reaction to the staphylococcus. In eleven cases of sycosis so tested, all gave positive reactions; six cases of sycosis which had been previously treated with
